J Korean Med Sci.  2020 Apr;35(19):e122. 10.3346/jkms.2020.35.e122.

Development of End Stage Renal Disease after Long-Term Ingestion of Chaga Mushroom: Case Report and Review of Literature

Affiliations
  • 1Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
  • 2Division of Nephrology, Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea
  • 3Division of Nephrology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
  • 4Transplant Research Center, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
  • 5Convergent Research Consortium for Immunologic Disease, Seoul St. Mary's Hospital, The Collage of Medicine, The Catholic University of Korea, Seoul, Korea
  • 6Hankook Renal Pathology Lab., Seoul, Korea

Abstract

Chaga mushrooms are widely used in folk remedies and in alternative medicine. Contrary to many beneficial effects, its adverse effect is rarely reported. We here report a case of end-stage renal disease after long-term taking Chaga mushroom. A 49-year-old Korean man with end stage renal disease (ESRD) was transferred to our hospital. Review of kidney biopsy finding was consistent with chronic tubulointerstitial nephritis with oxalate crystal deposits and drug history revealed long-term exposure to Chaga mushroom powder due to intractable atopic dermatitis. We suspected the association between Chaga mushroom and oxalate nephropathy, and measured the oxalate content of remained Chaga mushroom. The Chaga mushroom had extremely high oxalate content (14.2/100 g). Estimated daily oxalate intake of our case was 2 times for four years and 5 times for one year higher than that of usual diet. Chaga mushroom is a potential risk factor of chronic kidney disease considering high oxalate content. Nephrologist should consider oxalate nephropathy in ESRD patients exposed to Chaga mushrooms.

Keyword

Chaga Mushroom; End Stage Renal Disease; Oxalate Nephropathy

Figure

  • Fig. 1 Radiologic evaluation. (A) Chest posterioanterior view and (B) Kidney-Ureter-Bladder radiography show no evidence of vascular calcification or kidney stone. (C) Abdominal sonography revealed increased echogenicity and decreased kidney size. (D) The abdominal computed tomography shows no evidence of kidney stone or vascular calcification. The images are published under agreement of the patient.

  • Fig. 2 Histopathologic evaluation. (A) Tubules reveal focal severe necrosis with crystal deposits and denudation of tubular epithelial cells. H&E stain (×20). (B) Aggregates of crystals attached to tubular basement membrane are shown with denudation of tubular epithelial cells. H&E stain (× 40). (C) The same image as Fig. 2B observed under the polarizing microscope.H&E = haemotoxylin and eosin.


Reference

1. Kikuchi Y, Seta K, Ogawa Y, Takayama T, Nagata M, Taguchi T, et al. Chaga mushroom-induced oxalate nephropathy. Clin Nephrol. 2014; 81(6):440–444. PMID: 23149251.
Article
2. Lumlertgul N, Siribamrungwong M, Jaber BL, Susantitaphong P. Secondary Oxalate Nephropathy: A Systematic Review. Kidney Int Rep. 2018; 3(6):1363–1372. PMID: 30450463.
3. Sasaki M, Murakami M, Matsuo K, Matsuo Y, Tanaka S, Ono T, et al. Oxalate nephropathy with a granulomatous lesion due to excessive intake of peanuts. Clin Exp Nephrol. 2008; 12(4):305–308. PMID: 18335167.
Article
4. Lewandowski S, Rodgers A, Schloss I. The influence of a high-oxalate/low-calcium diet on calcium oxalate renal stone risk factors in non-stone-forming black and white South African subjects. BJU Int. 2001; 87(4):307–311. PMID: 11251520.
Article
5. Lewandowski S, Rodgers AL, Laube N, von Unruh G, Zimmermann D, Hesse A. Oxalate and its handling in a low stone risk vs a stone-prone population group. World J Urol. 2005; 23(5):330–333. PMID: 16283325.
Article
6. Beier RC. Natural pesticides and bioactive components in foods. Rev Environ Contam Toxicol. 1990; 113:47–137. PMID: 2404325.
Article
7. Glew RH, Sun Y, Horowitz BL, Konstantinov KN, Barry M, Fair JR, et al. Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease. World J Nephrol. 2014; 3(4):122–142. PMID: 25374807.
Article
8. Glamočlija J, Ćirić A, Nikolić M, Fernandes Â, Barros L, Calhelha RC, et al. Chemical characterization and biological activity of Chaga (Inonotus obliquus), a medicinal “mushroom”. J Ethnopharmacol. 2015; 162:323–332. PMID: 25576897.
Article
9. Shashkina MY, Shashkin PN, Sergeev AV. Chemical and medicobiological properties of chaga. [review]. Pharm Chem J. 2006; 40(10):560–568.
10. Chen CL, Fang HC, Chou KJ, Wang JS, Chung HM. Acute oxalate nephropathy after ingestion of star fruit. Am J Kidney Dis. 2001; 37(2):418–422. PMID: 11157385.
Article
11. Asano Y, Jinnin M, Kawaguchi Y, Kuwana M, Goto D, Sato S, et al. Diagnostic criteria, severity classification and guidelines of systemic sclerosis. J Dermatol. 2018; 45(6):633–691. PMID: 29687465.
Article
12. Hoppe B. An update on primary hyperoxaluria. Nat Rev Nephrol. 2012; 8(8):467–475. PMID: 22688746.
Article
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr